Cell Therapeutics, Stock Price 7,940 KRW (17.63%)... Bulletin Board 'Bustling'
At this time, posts about Cellma Therapeutics are rapidly increasing on portals and stock communities, and today, foreigners are tentatively estimated to have net purchased 2,000 shares. Cellma Therapeutics is known as a company distributing gift certificate discounts and dental materials.
As of 12:30 PM on the 22nd, Cellma Therapeutics' stock price is 7,940 KRW, up 17.63% from the previous day, with a trading volume of 5,812,214 shares, which is 209.3% of the 5-day average trading volume. On December 15th, Cellma Therapeutics became a market issue with the headline "Surge due to news of a mutant coronavirus."
In addition to Cellma Therapeutics, posts by investors are also rapidly increasing for GH Shinsosae (130500), Daehan Science (131220), and DB HiTek (000990).
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
